Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camostat mesilate oral wash for prevention of SARS-CoV-2 infection
jRCTs031200113Completed
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of camostat mesilate in coronavirus disease 2019 (COVID-19) (2 arms). Primary endpoint: SARS-CoV-2 PCR test positivity. Started Sep 2021; status: completed.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCTs031200113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200113.